Skip to content

A randomized controlled study on the treatment of severe acute pancreatitis with intraperitoneal hypertension through nasogastric nutrition tube administration of Gansui

A randomized controlled study on the treatment of severe acute pancreatitis with intraperitoneal hypertension through nasogastric nutrition tube administration of Gansui

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000034
Enrollment
Unknown
Registered
2024-03-21
Start date
2022-09-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe acute pancreatitis

Interventions

control group:Basic treatment +Indwelling nasojejacual nutrition tube
experimental group:Basic treatment + Nasal feeding of Gansui through a nasojejacual nutrition tube

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for "moderate severe acute pancreatitis" or "severe acute pancreatitis" (refer to the 2021 edition of Chinese Guidelines for Diagnosis and Treatment of Acute Pancreatitis); (2) Gansui can be administered through a nasojejacual nutrition tube; (3) Voluntarily participate in this study and sign an informed consent form; (4) Age = 18 and = 75 years old, regardless of gender.

Exclusion criteria

Exclusion criteria: (1) No gastrointestinal administration route; (2) Have a history of major digestive surgery in the past; (3) Patients who are currently participating in or have participated in other clinical trials within the month prior to this study; (4) Allergic reactions to therapeutic drugs; (5) Patients with fertility requirements or those who are pregnant or breastfeeding; (6) Liver function: Child Pugh C-grade; (7) Kidney function: CKD stage 4 or 5.

Design outcomes

Primary

MeasureTime frame
intra-abdominal pressure;

Secondary

MeasureTime frame
Abdominal perfusion pressure;Hospitalization expenses;lipase;CT severity index score;arterial oxygenation index, CO2 partial pressure;ICU hospitalization days;amylase;Incidence of complications;Hospitalization days;C-reactive protein;Procalcitonin;abdominal circumference;APACHE II score;White blood cell count, percentage of neutrophils;Ventilator parameters (mean airway pressure, airway resistance);Gastrointestinal motility score;

Countries

China

Contacts

Public Contactzhantao shen

Guangdong Provincial Hospital of Chinese Medicine

gzgentle@foxmail.com13535337248

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026